We are looking for 2–17 year olds to join a CD trial to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or IBD (including associated symptoms such as diarrhea with blood, loss of appetite, rectal pain, chronic fatigue and/or eye pain), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Act now.
